# Tres Alchemix Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tres-alchemix-co

- Industry: Biotechnology
- Headquarters: Fukuoka-shi, Japan
- Website: www.tresalchemix.com
- Total disclosed funding: $4.3M
- Latest round: Series A (Sep 26, 2025)
- Investors on record: 2

## About

Tres Alchemix Co. Ltd. is a Japan-based company focused on advancing drug development through innovative technologies, offering AI-driven models and quantum-level chemical calculations for pharmaceutical research.Founded in 2023, Tres Alchemix Co. Ltd. is headquartered in Fukuoka-shi, Japan, where it specializes in enhancing drug development processes. The company has completed 2 deals, and its most recent funding round was a Series A in September 2025, raising JPY 650 million led by DNX Ventures with participation from WASEDA University Ventures.Tres Alchemix focuses on leveraging advanced technologies to enhance the drug development process. The company’s primary offerings include sophisticated quantum-level chemical calculations and AI-driven models that utilize extensive biochemical and pharmacological datasets to predict chemical behavior in the human body, aimed at addressing complex challenges in chemical-protein interactions as well as pharmacokinetics and pharmacodynamics predictions. Their products target pharmaceutical companies and academic institutions engaged in drug research and development, with plans to expand into global markets including North America and Europe.Tres Alchemix generates revenue through partnerships and collaborations with pharmaceutical companies, academic institutions, and research laboratories. The firm employs a business-to-business (B2B) transaction model, providing AI-driven technologies for drug development and biological research. Revenue also includes subscription services for ongoing access to predictive modeling platforms, tailored to accommodate diverse client needs, including large pharmaceutical firms and research organizations.In September 2025, Tres Alchemix Co. Ltd. raised JPY 650 million in Series A funding to expedite the advancement of its artificial intelligence platform. The company plans to establish a new research laboratory at The Oxford Science Park in the UK, focusing on the development of upcoming products and services. Additionally, Tres Alchemix aims to expand into North American and European markets by leveraging its new funding to enhance its offerings and foster strategic partnerships.

## Funding rounds

- Series A, Sep 26, 2025, $4.3M — DNX Ventures, WASEDA University Ventures
- Seed, Aug 16, 2023 — WASEDA University Ventures

## Investors

- WASEDA University Ventures (https://capitalatlas.ai/funds/waseda-university-ventures) — Seed, Series A
- DNX Ventures (https://capitalatlas.ai/funds/dnx-ventures) — Series A